BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28089362)

  • 1. Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Kurahashi H; Yoshioka T; Ariyoshi Y; Kobayashi Y; Araki M; Ishii A; Watanabe M; Uehara S; Watanabe T; Nasu Y
    J Infect Chemother; 2017 Apr; 23(4):214-217. PubMed ID: 28089362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of oral azithromycin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Mitsui M; Araki M; Fujiyoshi M; Ishii A; Watanabe M; Watanabe T; Nasu Y
    J Infect Chemother; 2019 Oct; 25(10):832-834. PubMed ID: 31255523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of sitafloxacin against clinical isolates in 2012].
    Amano A; Matsuzaki K; Kishi N; Koyama H; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Okutani Y
    Jpn J Antibiot; 2013 Dec; 66(6):311-30. PubMed ID: 24649797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
    Huang H; Wang Y; Jiang C; Lang L; Wang H; Chen Y; Zhao Y; Xu Z
    Pulm Pharmacol Ther; 2014 Jun; 28(1):49-52. PubMed ID: 24211813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed Pharmacokinetic-Pharmacodynamic Breakpoint of Garenoxacin and Other Quinolones.
    Yamagishi Y; Shibata T; Nakagawa S; Nomura N; Mitsuyama J; Mikamo H
    Jpn J Infect Dis; 2017 Nov; 70(6):616-620. PubMed ID: 28890509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of sitafloxacin against clinical isolates in 2009].
    Amano A; Matsuzaki K; Kishi N; Saika T; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Kanda Y; Shiozawa T
    Jpn J Antibiot; 2010 Dec; 63(6):411-30. PubMed ID: 21425595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone improves therapeutic outcomes in a preclinical bacterial epididymitis mouse model.
    Klein B; Pant S; Bhushan S; Kautz J; Rudat C; Kispert A; Pilatz A; Wijayarathna R; Middendorff R; Loveland KL; Hedger MP; Meinhardt A
    Hum Reprod; 2019 Jul; 34(7):1195-1205. PubMed ID: 31211847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin].
    Saito I; Suzuki A; Saiko Y; Yokozawa M; Ono K; Miyata K; Miyamura R; Hamaya O; Kaneko K; Yamamoto T
    Hinyokika Kiyo; 1992 May; 38(5):623-8. PubMed ID: 1609677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of hemiacetal esterified levofloxacin to prevent chelation with metal-containing drugs.
    Otori T; Matzno S; Kawase A; Iwaki M; Kimachi T; Nishiwaki K; Figoni WC; Tominaga R; Asahide M; Nishikata M; Ishii Y; Matsuyama K
    J Pharm Pharmacol; 2016 Dec; 68(12):1527-1534. PubMed ID: 27774590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.
    Li Y; Yin Y; Peng X; Zheng H; Fu F; Liu Z; Wu X; Wu X; Zheng S; Chen N; He L; Ren L; Ni Z; Li D; Liang P; Lv X; Zhang Y
    Ann Med; 2021 Dec; 53(1):217-226. PubMed ID: 33331182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats.
    Shinmachi K; Takahashi Y; Kaneuji Y; Kawamura R; Kohama K; Hieda Y; Goromaru T; Eto S; Murakami T; Maeda Y
    Pharmazie; 2020 Nov; 75(11):554-558. PubMed ID: 33239128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva.
    Suzuki T; Yamamoto T; Ohashi Y
    J Infect Chemother; 2016 Jun; 22(6):360-5. PubMed ID: 27036073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs.
    Landoni MF; Albarellos GA
    J Vet Pharmacol Ther; 2019 Mar; 42(2):171-178. PubMed ID: 30302775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of levofloxacin in Korean patients.
    Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL
    J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of unbound levofloxacin by simultaneous microdialysis in rat pancreas after intravenous and oral doses.
    Liu D; Xu S; Xiao H; Wang Z; Mao N; Zhou J; Liu R; Huang Y
    J Pharm Pharmacol; 2014 Sep; 66(9):1215-21. PubMed ID: 24961375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
    Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
    Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures.
    Szerkus O; Jacyna J; Wiczling P; Gibas A; Sieczkowski M; Siluk D; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():48-59. PubMed ID: 27423043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of clinically-isolated bacteria strains to respiratory quinolones and evaluation of antimicrobial agent efficacy by Monte Carlo simulation].
    Kosaka T; Yamada Y; Kimura T; Kodama M; Fujitomo Y; Masaki N; Toshiaki K; Keisuke S; Fujita N
    Jpn J Antibiot; 2016 Feb; 69(1):27-40. PubMed ID: 27290828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.